The major functions of the Study Design and Clinical Research Core are to (1) serve clinical and basic science investigators in digestive diseases with comprehensive study design consultation and support, (2) assist DDC investigators in all aspects of the acquisition of clinical specimens required for their research in digestive diseases, and (3) support comprehensive data analyses and interpretation of basic, translation, clinical and epidemiological studies. The Core has been highly productive and beneficial for members of the TMC DDC. In the last 4 years, 29 members used the study design consultation and support services, 49 DDC members used the statistical component of the Core, and 13 members obtained help with specimen acquisition and handling. This Core is primarily a DDC Core; 75% of Core users in the last 2 years were either full or associate members of the DDC. Over 50 members anticipate using this Core in the next project period. Major Core services include providing study-design and statistical-analysis support; establishing procedures for data management and database organization to facilitate efficient analyses; assisting DDC investigators in acquiring clinical specimens needed for their research; assisting and training in compliance, patient confidentiality and oversight issues, including preparation of IRB requests and preparation of Investigational New Drug (IND) applications; and training. The Clinical Core fulfills an important need for the DDC investigators at Baylor College of Medicine (BCM), where there is no department of epidemiology or biostatistics or a funded Clinical Translational Science Award grant. For the new funding period, Core E will continue to support ongoing and innovative research to prevent and cure digestive diseases. We also propose new DDC member-exclusive services that include cutting edge statistical analyses, enhanced research coordination service, and establishment of a enteroid biorepository. Both Core Co-Directors brings a unique area of expertise in clinical, translational, and epidemiological research, namely sample and tissue collection, epidemiology and health services research, and biostatistics. Advances during the current funding period include the expansion of sample and tissue collection and banking, and the increased number of requests involving epidemiology and health outcomes research, especially those using electronic databases to capture large amounts of patient information, risk factors, therapies, and outcomes; these databases include large disease registries and healthcare claims data. During the current award cycle, the has been critically involved in developing the new service in the newly reorganized GEMS Core of the DDC, providing human organoids to DDC investigators. The Core will continue to support establishment of the enteroid biorepository and expand the specimen collection service to collect tissue from livers. This service is highly sought after and will be shared with researchers studying gastrointestinal injury and inflammation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK056338-18
Application #
9932430
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
18
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Hernaez, Ruben; Kanwal, Fasiha; El-Serag, Hashem B (2018) Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis. Hepatology 68:7-9
Kramer, J R; Puenpatom, A; Erickson, K F et al. (2018) Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system. J Viral Hepat 25:1270-1279
Stewart, Christopher J; Auchtung, Thomas A; Ajami, Nadim J et al. (2018) Effects of tobacco smoke and electronic cigarette vapor exposure on the oral and gut microbiota in humans: a pilot study. PeerJ 6:e4693
Ihekweazu, Faith D; Versalovic, James (2018) Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci 356:413-423
Chiang, Yun-Chen; Park, In-Young; Terzo, Esteban A et al. (2018) SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma. Cancer Res 78:3135-3146
Hu, Liya; Sankaran, Banumathi; Laucirica, Daniel R et al. (2018) Glycan recognition in globally dominant human rotaviruses. Nat Commun 9:2631
Fekry, Baharan; Ribas-Latre, Aleix; Baumgartner, Corrine et al. (2018) Incompatibility of the circadian protein BMAL1 and HNF4? in hepatocellular carcinoma. Nat Commun 9:4349
Robayo-Torres, Claudia C; Diaz-Sotomayor, Marisela; Hamaker, Bruce R et al. (2018) 13C-Labeled-Starch Breath Test in Congenital Sucrase-isomaltase Deficiency. J Pediatr Gastroenterol Nutr 66 Suppl 3:S61-S64
Menon, Renuka T; Shrestha, Amrit Kumar; Barrios, Roberto et al. (2018) Hyperoxia Disrupts Extracellular Signal-Regulated Kinases 1/2-Induced Angiogenesis in the Developing Lungs. Int J Mol Sci 19:
Liu, Yanhong; O'Brien, Jacqueline L; Ajami, Nadim J et al. (2018) Lung tissue microbial profile in lung cancer is distinct from emphysema. Am J Cancer Res 8:1775-1787

Showing the most recent 10 out of 1121 publications